Blood-Brain Barrier Imaging in Human Neuropathologies

Archives of Medical Research

Volumn 45, Issue 8, 2014, Pages 646-652

  Veksler, Ronel ^a   Shelef, Ilan ^b   Friedman, Alon ^a,c  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Blood brain barrier; Magnetic resonance; Neuropathologies; Neurovascular

Indexed keywords

ANALYTIC METHOD; BLOOD BRAIN BARRIER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; HUMAN; IMAGE ANALYSIS; MINIMALLY INVASIVE PROCEDURE; NERVE DEGENERATION; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BRAIN INJURIES; IMAGE PROCESSING; NEURODEGENERATIVE DISEASES; PATHOLOGY; PROCEDURES; SCINTISCANNING;

BLOOD-BRAIN BARRIER; BRAIN INJURIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; NEURODEGENERATIVE DISEASES; NEUROIMAGING; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84924766597     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2014.11.016     Document Type: Review

References (68)

1. Abbott N.J., Patabendige A.A., Dolman D.E., et al. Structure and function of the blood-brain barrier. Neurobiol Dis 2010, 37:13-25.
2. Balami J.S., Chen R.L., Grunwald I.Q., et al. Neurological complications of acute ischaemic stroke. Lancet Neurol 2011, 10:357-371.
3. Khatri R., McKinney A.M., Swenson B., et al. Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. Neurology 2012, 79(Suppl 1):S52-S57.
4. Edgell R.C., Vora N.A. Neuroimaging markers of hemorrhagic risk with stroke reperfusion therapy. Neurology 2012, 79(Suppl 1):S100-S104.
5. Hjort N., Wu O., Ashkanian M., et al. MRI detection of early blood-brain barrier disruption: parenchymal enhancement predicts focal hemorrhagic transformation after thrombolysis. Stroke 2008, 39:1025-1028.
6. Latour L.L., Kang D.W., Ezzeddine M.A., et al. Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol 2004, 56:468-477.
7. Pavlovsky L., Seiffert E., Heinemann U., et al. Persistent BBB disruption may underlie alpha interferon-induced seizures. J Neurol 2005, 252:42-46.
8. Tomkins O., Shelef I., Kaizerman I., et al. Blood-brain barrier disruption in post-traumatic epilepsy. J Neurol Neurosurg Psychiatr 2008, 79:774-777.
9. Seiffert E., Dreier J.P., Ivens S., et al. Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci 2004, 24:7829-7836.
10. Tomkins O., Friedman O., Ivens S., et al. Blood-brain barrier disruption results in delayed functional and structural alterations in the rat neocortex. Neurobiol Dis 2007, 25:367-377.
11. David Y., Cacheaux L.P., Ivens S., et al. Astrocytic dysfunction in epileptogenesis: consequence of altered potassium and glutamate homeostasis?. J Neurosci 2009, 29:10588-10599.
12. Friedman A., Kaufer D., Heinemann U. Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy. Epilepsy Res 2009, 85:142-149.
13. Ivens S., Kaufer D., Flores L.P., et al. TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 2007, 130:535-547.
14. Tomkins O., Feintuch A., Benifla M., et al. Blood-brain barrier breakdown following traumatic brain injury: a possible role in posttraumatic epilepsy. Cardiovasc Psychiatry Neurol 2011, 2011:765923.
15. Lapilover E.G., Lippmann K., Salar S., et al. Peri-infarct blood-brain barrier dysfunction facilitates induction of spreading depolarization associated with epileptiform discharges. Neurobiol Dis 2012, 48:495-506.
16. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010, 9:689-701.
17. Wardlaw J.M., Smith C., Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 2013, 12:483-497.
18. Schreiber S., Bueche C.Z., Garz C., et al. Blood brain barrier breakdown as the starting point of cerebral small vessel disease?-New insights from a rat model. Exp Transl Stroke Med 2013, 5:4.
19. Hawkins B.T., Davis T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005, 57:173-185.
20. Abbott N.J., Ronnback L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006, 7:41-53.
21. Shlosberg D., Benifla M., Kaufer D., et al. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol 2010, 6:393-403.
22. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.
23. Marchi N., Bazarian J.J., Puvenna V., et al. Consequences of repeated blood-brain barrier disruption in football players. PLoS One 2013, 8:e56805.
24. Zlokovic B.V. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 2011, 12:723-738.
25. Bar-Klein G., Cacheaux L.P., Kamintsky L., et al. Losartan prevents acquired epilepsy via TGF-β signaling suppression. Ann Neurol 2014, 21(75):864-875.
26. Sivanandam T.M., Thakur M.K. Traumatic brain injury: a risk factor for Alzheimer's disease. Neurosci Biobehav Rev 2012, 36:1376-1381.
27. Bailes J.E., Petraglia A.L., Omalu B.I., et al. Role of subconcussion in repetitive mild traumatic brain injury. J Neurosurg 2013, 119:1235-1245.
28. Shahim P., Tegner Y., Wilson D.H., et al. Blood biomarkers for brain injury in concussed professional ice hockey players. J Am Med Assoc Neurol 2014, 71:684-692.
29. Koerte I.K., Ertl-Wagner B., Reiser M., et al. White matter integrity in the brains of professional soccer players without a symptomatic concussion. J Am Med Assoc 2012, 308:1859-1861.
30. Hom J., Dankbaar J.W., Soares B.P., et al. Blood-brain barrier permeability assessed by perfusion CT predicts symptomatic hemorrhagic transformation and malignant edema in acute ischemic stroke. AJNR Am J Neuroradiol 2011, 32:41-48.
31. Ozkul-Wermester O., Guegan-Massardier E., Triquenot A., et al. Increased blood-brain barrier permeability on perfusion computed tomography predicts hemorrhagic transformation in acute ischemic stroke. Eur Neurol 2014, 72:45-53.
32. Lansberg M.G., Thijs V.N., Bammer R., et al. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke 2007, 38:2275-2278.
33. Lorberboym M., Lampl Y., Sadeh M. Correlation of 99mTc-DTPA SPECT of the blood-brain barrier with neurologic outcome after acute stroke. J Nucl Med 2003, 44:1898-1904.
34. Gilad R., Lampl Y., Eilam A., et al. SPECT-DTPA as a tool for evaluating the blood-brain barrier in post-stroke seizures. J Neurol 2012, 259:2041-2044.
35. Jackson A. Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma. Br J Radiol 2003, 76:153-162.
36. Alonzi R., Taylor N.J., Stirling J.J., et al. Reproducibility and correlation between quantitative and semiquantitative dynamic and intrinsic susceptibility-weighted MRI parameters in the benign and malignant human prostate. J Magn Reson Imaging 2010, 32:155-164.
37. Roberts C., Issa B., Stone A., et al. Comparative study into the robustness of compartmental modeling and model-free analysis in DCE-MRI studies. J Magn Reson Imaging 2006, 23:554-563.
38. Tofts P.S., Brix G., Buckley D.L., et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999, 10:223-232.
39. Sourbron S., Ingrisch M., Siefert A., et al. Quantification of cerebral blood flow, cerebral blood volume, and blood-brain-barrier leakage with DCE-MRI. Magn Reson Med 2009, 62:205-217.
40. Roberts C., Buckley D.L., Parker G.J.M. Comparison of errors associated with single- and multi-bolus injection protocols in low-temporal-resolution dynamic contrast-enhanced tracer kinetic analysis. Magn Reson Med 2006, 56:611-619.
41. Cao Y., Li D., Shen Z., et al. Sensitivity of quantitative metrics derived from DCE MRI and a pharmacokinetic model to image quality and acquisition parameters. Acad Radiol 2010, 17:468-478.
42. Kershaw L.E., Cheng H.L.M. Temporal resolution and SNR requirements for accurate DCE-MRI data analysis using the AATH model. Magn Reson Med 2010, 64:1772-1780.
43. Larsson C., Kleppestø M., Rasmussen I., et al. Sampling requirements in DCE-MRI based analysis of high grade gliomas: simulations and clinical results. J Magn Reson Imaging 2013, 37:818-829.
44. Deoni S.C., Peters T.M., Rutt B.K. High-resolution T1 and T2 mapping of the brain in a clinically acceptable time with DESPOT1 and DESPOT2. Magn Reson Med 2005, 53:237-241.
45. Treier R., Steingoetter A., Fried M., et al. Optimized and combined T1 and B1 mapping technique for fast and accurate T1 quantification in contrast-enhanced abdominal MRI. Magn Reson Med 2007, 57:568-576.
46. Sourbron S.P., Buckley D.L. Classic models for dynamic contrast-enhanced MRI. NMR Biomed 2013, 26:1004-1027.
47. Tofts P.S. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997, 7:91-101.
48. Murase K. Efficient method for calculating kinetic parameters using T1-weighted dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Med 2004, 51:858-862.
49. Sourbron S.P., Buckley D.L. On the scope and interpretation of the Tofts models for DCE-MRI. Magn Reson Med 2011, 66:735-745.
50. Luypaert R., Ingrisch M., Sourbron S., et al. The Akaike information criterion in DCE-MRI: does it improve the haemodynamic parameter estimates?. Phys Med Biol 2012, 57:3609-3628.
51. Shi L., Wang D., Liu W., et al. Automatic detection of arterial input function in dynamic contrast enhanced MRI based on affinity propagation clustering. J Magn Reson Imaging 2013, 39:1327-1337.
52. Bergamino M., Bonzano L., Levrero F., et al. A review of technical aspects of T1-weighted dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in human brain tumors. Phys Med 2014, 30:635-643.
53. Bleeker E.J., Webb A.G., van Walderveen M.A., et al. Evaluation of signal formation in local arterial input function measurements of dynamic susceptibility contrast MRI. Magn Reson Med 2012, 67:1324-1331.
54. Calamante F., Morup M., Hansen L.K. Defining a local arterial input function for perfusion MRI using independent component analysis. Magn Reson Med 2004, 52:789-797.
55. Willats L., Christensen S., Ma H.K., et al. Validating a local Arterial Input Function method for improved perfusion quantification in stroke. J Cereb Blood Flow Metab 2011, 31:2189-2198.
56. Fluckiger J.U., Schabel M.C., DiBella E.V.R. Toward local arterial input functions in dynamic contrast-enhanced MRI. J Magn Reson Imaging 2010, 32:924-934.
57. Sahoo P., Rathore R.K.S., Awasthi R., et al. Subcompartmentalization of extracellular extravascular space (EES) into permeability and leaky space with local arterial input function (AIF) results in improved discrimination between high- and low-grade glioma using dynamic contrast-enhanced (DCE) MRI. J Magn Reson Imaging 2013, 38:677-688.
58. Jelescu I.O., Leppert I.R., Narayanan S., et al. Dual-temporal resolution dynamic contrast-enhanced MRI protocol for blood-brain barrier permeability measurement in enhancing multiple sclerosis lesions. J Magn Reson Imaging 2011, 33:1291-1300.
59. Heye A.K., Culling R.D., Valdés Hernández M.D., et al. Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review. NeuroImage Clin 2014, 6:262-274.
60. Bisdas S., Naegele T., Ritz R., et al. Distinguishing recurrent high-grade gliomas from radiation injury: a pilot study using dynamic contrast-enhanced MR imaging. Acad Radiol 2011, 18:575-583.
61. O'Connor J.P.B., Jackson A., Parker G.J.M., et al. Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies. Nat Rev Clin Oncol 2012, 9:167-177.
62. Walker-Samuel S., Leach M.O., Collins D.J. Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis. Phys Med Biol 2006, 51:3593-3602.
63. Karahaliou A., Vassiou K., Arikidis N.S., et al. Assessing heterogeneity of lesion enhancement kinetics in dynamic contrast-enhanced MRI for breast cancer diagnosis. Br J Radiol 2010, 83:296-309.
64. Chassidim Y., Veksler R., Lublinsky S., et al. Quantitative imaging assessment of blood-brain barrier permeability in humans. Fluids Barriers CNS 2013, 10:9.
65. Zach L., Guez D., Last D., et al. Delayed contrast extravasation MRI for depicting tumor and non-tumoral tissues in primary and metastatic brain tumors. PLoS One 2012, 7:e52008.
66. Daniels D., Guez D., Last D., et al. Group T a. P16.35 * Delayed contrast MRI for differentiating tumor from treatment effects in conventional and anti-angiogenic treatments. Neuro Oncol 2014, 16(Suppl 2). ii86.
67. Ingrisch M., Sourbron S. Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer. J Pharmacokinet Pharmacodyn 2013, 40:281-300.
68. Taheri S., Gasparovic C., Shah N.J., et al. Quantitative measurement of blood-brain barrier permeability in human using dynamic contrast-enhanced MRI with fast T1 mapping. Magn Reson Med 2011, 65:1036-1042.